Cardiology Hormones Life Science 
The Pharma Data
FEBRUARY 21, 2022
Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.
XTalks
NOVEMBER 19, 2021
Natriuretic peptides like N-terminal (NT)-pro hormone B type natriuretic peptide (NT-proBNP), or BNP, are routinely used for acute and chronic heart failure. This is a part of the precision cardiology approach and could lead to their use as prognostic indicators. The Double-Edged Sword of Cardiac Biomarkers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
FEBRUARY 8, 2024
Diabetes remains a critical global challenge, affecting millions of lives and commanding significant attention from the medical, life sciences and pharmaceutical sectors. Understanding the market dynamics of diabetes treatments becomes crucial for professionals across these industries.
XTalks
SEPTEMBER 11, 2024
It wasn’t until 1999, when the American Heart Association released its Guide to Preventive Cardiology for Women , that the medical field acknowledged that women show different symptoms of the disease than men. Polycystic ovary syndrome (PCOS), affecting hormone levels, metabolism and overall health, can also benefit from precision medicine.
XTalks
AUGUST 2, 2023
5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. It is a CDK 4/6 inhibitor that is taken in combination with other hormonal therapies to stop the growth of cancer and healthy cells. billion in 2022.
Expert insights. Personalized for you.
52 
Let's personalize your content